已收盘 08-21 16:00:00 美东时间
+0.400
+1.33%
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Goldman Sachs analyst Richard Law upgraded Protagonist Therapeutics Inc (NASDAQ:PTGX) from Neutra...
08-10 20:07
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24
In a report released today, Matthew Bouley from Barclays upgraded James Hardie ...
08-10 15:56
U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Friday. Shares of Natera Inc (NASDAQ:NTRA) rose sharply after the company reported better-than-expected quarterly financial results and raised its FY26 sales guidance above estimates. The company reported a second-quarter loss o...
08-08 03:35
Truist Securities analyst Keith Hughes maintains James Hardie Industries (NYSE:JHX) with a Buy and raises the price target from $30 to $40.
08-07 21:21
华盛资讯8月7日讯,詹姆斯哈迪公布2026财年Q2业绩,公司Q2营收14.75亿美元,同比增长63.9%,归母净利润1.04亿美元,同比增长66.6%。
08-07 07:09
华盛资讯8月7日讯,詹姆斯哈迪公布2026财年Q2业绩,公司Q2营收14.75亿美元,同比增长63.9%,归母净利润1.04亿美元,同比增长66.6%。
08-07 05:16